New multiple sclerosis drug by Sanofi delays progressive form of disease by 31 per cent in trial
- Posted on September 20, 2024
- By The Globe and Mail
- 1 Views
New multiple sclerosis drug by Sanofi delays progressive form of disease by 31 per cent in trial
Sanofi is pursuing several opportunities in MS, a debilitating nerve disease, to offset revenue losses after the recent end of MS pill Aubagio’s patent protection
